Clinical trials: Improvement the Treatment of the Patient
Acute Leukemia, Recurrent Leukemia
Bright White Light Therapy for the Improvement of Sleep, Fatigue, Distress, Depression, and Anxiety in Hospitalized Leukemia Patients
This trial investigates how well bright white light therapy works in improving sleep, fatigue, distress, depression, and anxiety, side effects that are often experienced during an intense leukemia treatment regimen, in…
- Conditions
- Acute Leukemia, Recurrent Leukemia, Refractory Leukemia
- Trial name
- NCT04597086
- Testing
- Best Practice, Bright White Light Therapy, Survey Administration
- Where
- United States
- Volunteers
- 74 people
- Sponsor
- Ohio State University Comprehensive Cancer Center
Gynecologic Cancer
To Explore the Benefits of the MonaLisa Touch® System in Gynaecological Cancer Patients Treated by (Chemo)-RT
The increasing survival rate of gynaecological cancer patients highlights the need to improve their Quality of Life (QoL) after treatment.
- Trial name
- SQUAL (NCT05891470)
- Testing
- MonaLisa Touch device, Vaginal dilatators
- Where
- Belgium
- Volunteers
- 136 people
- Sponsor
- Jules Bordet Institute
IVF, Infertility
Improvement of Fertilization Rate and Embryo Quality by Treating Calcium Ionophore in IVF Patients: a Sibling Oocyte Control Study
GM508 CultActive is a bicarbonate buffered reagent and ready-to-use designed to investigate oocytes of patients with failed fertilization after previous Intracytoplasmatic Sperm Injection cycles.
- Conditions
- IVF, Infertility, Artificial Oocyte Activation
- Trial name
- GM508 in IVF (NCT05722067)
- Testing
- calcium ionophore
- Where
- Taiwan
- Volunteers
- 68 people
- Sponsor
- Chang Gung Memorial Hospital
Congenital Erythropoietic Porphyria (CEP)
A Study to Investigate the Improvement of Photosensitivity in Terms of Skin Lesions Associated With CEP Following Administration of Oral ATL-001 (Ciclopirox Oral Solution) in Participants Aged >18 Years of Age With CEP
This is a study to investigate the effect of oral ATL-001 (ciclopirox) in CEP (Congenital Erythropoietic Porphyria) patients. During the study, it will be measured the improvement of skin lesions, fatigue and other clinical…
- Trial name
- ATL001-PII-CEP (NCT07024316)
- Testing
- ATL-001 (Ciclopirox oral solution)
- Where
- United States
- Volunteers
- 6 people
- Sponsor
- Atlas Molecular Pharma
Immunophenotyping Blood Samples of Patients With Osteoporosis
Immunophenotyping in Patients With Osteoporosis
In addition to a medical history and clinical examination, the diagnosis of osteoporosis includes the measurement of bone surface density by means of dual X-ray absorptiometry (DXA).
- Trial name
- IPO (NCT05132348)
- Testing
- Immunological markers
- Where
- Germany
- Volunteers
- 250 people
- Sponsor
- University Hospital, Bonn
Non-Small-Cell Lung Cancer
Evaluation of Symptoms Improvement in NSCLC Patients With First-Line Therapy of EGFR Tyrosine Kinase Inhibitor
This is an open-label, non-interventional, single-arm, multicenter study in a real-world population to assess the clinically symptom improvement and quality of life (QoL) in patients with locally advanced or metastatic NSCLC and…
- Trial name
- NCT01947868
- Where
- Taiwan
- Volunteers
- 346 people
- Sponsor
- AstraZeneca
Philadelphia Positive (Ph+) Chronic Myeloid Leukemia
Trial to Evaluate the Improvement of Chronic Low-grade AEs in Patients With Ph+ CML With Optimal Response to Imatinib When Switched to Nilotinib
Primary Objective for this study is to evaluate changes in chronic low grade non-hematological adverse events experienced by patients who have been treated with at least 6 months of imatinib and who have not responded to…
- Trial name
- MACS1532 (NCT02115386)
- Testing
- Nilotinib
- Where
- Russia
- Volunteers
- 7 people
- Sponsor
- Novartis Pharmaceuticals
Overactive Bladder, Hyperthermia
The Effect and Safety of Moxibustion Therapy for Overactive Bladder Patients
This pragmatic randomized controlled study aimed to evaluate the effectiveness and safety of moxibustion therapy on overactive bladder (OAB) patients.
- Conditions
- Overactive Bladder, Hyperthermia, Urinary Frequency or Urgency Adverse Event, Lower Urinary Tract Symptoms
- Trial name
- NCT02271607
- Testing
- moxibustion
- Where
- South Korea
- Volunteers
- 24 people
- Sponsor
- Korean Medicine Hospital of Pusan National University
Pelvic Floor Disorders
Combination Treatment With BTL-899 and HPM-6000UF Devices
This study will evaluate the clinical efficacy of the BTL-899 and HPM-6000UF devices in combination for non-invasive strengthening of the core muscles and overall improvement in quality of life in elderly patients.
- Trial name
- NCT05537181
- Testing
- BTL-899; HPM-6000UF Treatments
- Where
- 3 sites in United States
- Volunteers
- 39 people, healthy volunteers welcome
- Sponsor
- BTL Industries Ltd.
Pulmonary Disease, Chronic Obstructive
Comparing the Efficacy of Tiotropium + Olodaterol Fixed Dose Combination (FDC) Over Tiotropium in Improvement of Lung Hyperinflation, Exercise Capacity and Physical Activity in Japanese COPD Patients
This is a multi-centre, randomised, double-blinded, active-controlled, 2-way cross over trial to assess the effects of once daily administration of orally inhaled tiotropium + olodaterol FDC or tiotropium (both delivered by the…
- Trial name
- NCT02629965
- Testing
- tiotropium, olodaterol
- Where
- 43 sites in Japan
- Volunteers
- 184 people
- Sponsor
- Boehringer Ingelheim
Problematic Use of Mobile Phones
Cognitive Behavioral Therapy for Mobile Phone Addiction in Hospitalized Patients
Problematic mobile phone use is excessive dependence and use of electronic products and their functions, which affects the daily life of users.
- Trial name
- CBT (NCT07457658)
- Testing
- Cognitive-behavioral therapy, Traditional treatment in the ward
- Where
- China
- Volunteers
- 140 people
- Sponsor
- Sir Run Run Shaw Hospital
Patient Compliance
A Randomized Controlled Trial to Assess the Effect of L-carnitine in Patients With Diabetic Peripheral Neuropathy to Relief Pain and Symptom Improvement
Diabetic Peripheral Neuropathy (DPN) is a common complication of diabetes mellitus. The prevalence rate is approaching towards a peak throughout the world including Bangladesh.
- Trial name
- NCT04145245
- Testing
- Levocarnitine
- Where
- Bangladesh
- Volunteers
- 104 people
- Sponsor
- Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Fibromyalgia, Chronic Pain
Medical Benefit Evaluation of Ambulatory Activity Combining Rehabilitation and Therapeutic Education, Using an Intelligent Electric Bike for the Health, for the Effort Rehabilitation and the Quality of Life Improvement for Patients Suffering of Moderate Fibromyalgia (FIBROVELIS)
The aim of this study is to decrease the impact of the fibromyalgia on the daily quality of life of the patients suffering of moderate fibromyalgia at 6 months by the practice of an adapted physical activity coupled with…
- Conditions
- Fibromyalgia, Chronic Pain, Adapted Physical Activity, Therapeutic Education
- Trial name
- Fibrovelis (NCT04318054)
- Testing
- Ambulatory activity combining rehabilitation and therapeutic education, using an Intelligent Electric Bike for the Health.
- Volunteers
- 56 people
- Sponsor
- University Hospital, Grenoble
Diabetes Mellitus, Type 2
Reusing Needles for Subcutaneous Insulin Injection in Patients With Type 2 Diabetes
A randomized clinical trial (RCT) will be carried out to compare the reuse or not of needles in patients with type 2 diabetes (T2DM) that use insulin.
- Trial name
- NCT05407233
- Testing
- Does not reuse the syringe for insulin application, Uses the syringe for insulin delivery five times
- Where
- Brazil
- Volunteers
- 71 people
- Sponsor
- Hospital de Clinicas de Porto Alegre
Xerostomia, Hyposalivation
A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA Study
The purpose of this study is to evaluate the clinical efficacy, safety and acceptability of our new oral salivary equivalent in the relief of signs and symptoms related to mouth dryness as compared to two distinct moisturizing…
- Conditions
- Xerostomia, Hyposalivation, Head and Neck Cancer, Sjögren Syndrome
- Trial name
- NIAGARA (NCT02049112)
- Testing
- Salivary equivalent, Aequasyal, Biotene
- Where
- France
- Volunteers
- 210 people
- Sponsor
- Unither Pharmaceuticals, France